Evergreen Youth Secrets
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
  • Health News
  • Health Care
  • Staying Healthy
  • Beauty Advices
No Result
View All Result
Evergreen Youth Secrets
No Result
View All Result
Home Health Care

Ozempic reduces knee osteoarthritis pain by almost half: Study

by
October 31, 2024
in Health Care
0
Ozempic reduces knee osteoarthritis pain by almost half: Study

The results of a clinical trial published this week found that the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was linked with a near halving of reported pain among patients with knee osteoarthritis and obesity.

The study funded by Novo Nordisk, the manufacturer of Ozempic and Wegovy, involved 407 participants taking either the active ingredient semaglutide or a placebo for 68 weeks. Roughly 82 percent of participants were women.

To measure pain, researchers used the Western Ontario and McMaster Universities Arthritis Index (WOMAC). The WOMAC involves participants scoring pain, difficulty and physical function when doing everyday activities like walking up and down stairs or sitting.

At the start of the trial, the average WOMAC pain score among participants was 70.9. By the 68th week, those taking semaglutide reported an average WOMAC pain score of 29.2, while those taking a placebo reported an average pain score of 43.4.

The semaglutide participants on average had a body weight reduction of 13.7 percent, while those taking a placebo had a 3.2 percent reduction on average.

“Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater reductions in body weight and pain related to knee osteoarthritis than placebo,” the study’s conclusion stated.

As the Johns Hopkins Arthritis Center notes, overweight women have almost four times the risk of developing knee osteoarthritis when compared to non-obese women. For obese men, the risk is five times higher than their non-obese counterparts.

GLP-1 agonists like semaglutide have been explored for uses beyond obesity and diabetes. Semaglutide has been studied for potential benefits for treating addiction, kidney failure, liver disease and early Alzheimer’s disease.

Previous Post

Lawsuit challenges Louisiana law classifying mifepristone, misoprostol as controlled substances

Next Post

Trump: RFK Jr. will work on ‘health and women’s health’

Next Post
Trump: RFK Jr. will work on ‘health and women’s health’

Trump: RFK Jr. will work on 'health and women's health'

Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

    Popular News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025
    Bird flu can live in raw milk for more than a week, study finds

    Bird flu can live in raw milk for more than a week, study finds

    June 6, 2025

    Trending

    New York law now requires paid breaks for breastfeeding employees 

    New York law now requires paid breaks for breastfeeding employees 

    June 19, 2024
    Senate Dems demand Kennedy disclose details of Mar-a-Lago meetings with drug execs

    Senate Dems demand Kennedy disclose details of Mar-a-Lago meetings with drug execs

    March 11, 2025
    Maternal deaths rise, reversing two-year trend

    Maternal deaths rise, reversing two-year trend

    April 30, 2025
    Ocasio-Cortez: People experience denied claims as ‘act of violence’

    Ocasio-Cortez: People experience denied claims as ‘act of violence’

    December 12, 2024

    Recent News

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges

    June 6, 2025
    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    June 6, 2025

    Popular News

    • A West Virginia prosecutor is warning women that a miscarriage could lead to criminal charges
    • Kash Patel claims ‘breakthrough’ in Fauci COVID origins probe

    About Evergreen Youth Secrets

    • Contact us
    • Privacy Policy
    • Terms & Conditions
    • Email Whitelisting

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.

    No Result
    View All Result
    • Health News
    • Health Care
    • Staying Healthy
    • Beauty Advices

    Copyright © 2025 Evergreenyouthsecrets.com. All Rights Reserved.